Clinical Trials Browser

Gastrointestinal Neoplasms, Urogenital Neoplasms

NCT01851395 2026-03-11

Rapid Autopsy and Procurement of Cancer Tissue

Recruiting

275 enrolled

Other solid neoplasmThoracic

Lung Neoplasms, Mesothelioma, Thymus Neoplasms, Urogenital Neoplasms

NCT04354064 2026-02-20

Circulating Tumor DNA (ctDNA) for Early Treatment Response Assessment of Solid Tumors

Recruiting

100 enrolled

BreastDermatologicGastrointestinalGenitourinaryHead & NeckSarcomaThoracic

Breast Neoplasms, Colonic Neoplasms, Esophageal Neoplasms, Gastrointestinal Neoplasms, Head and Neck Neoplasms, Lung Neoplasms, Melanoma, Prostatic Neoplasms, Sarcoma, Skin Neoplasms, Urogenital Neoplasms

NCT06724159 2026-02-17

SOGUG-PRINCIS

Recruiting

500 enrolled

Genitourinary

Carcinoma, Renal Cell, Carcinoma, Transitional Cell, Urogenital Neoplasms

NCT06738797 2026-01-28

PROMES-URO

Recruiting

32 enrolled

Urogenital Neoplasms

NCT04923178 2026-01-26

A Multi-Center Natural History of Urothelial Cancer and Rare Genitourinary Tract Malignancies

Recruiting

1,100 enrolled

Genitourinary

Urachal adenocarcinoma, Urinary Bladder Neoplasms, Carcinoma, Renal Cell, Penile Neoplasms, Urogenital Neoplasms

NCT06795087 2026-01-22

Discharge Medication Use Post-Operatively in GU Cancer Patients

Recruiting

684 enrolled

Urogenital Neoplasms

NCT01505400 2026-01-08

IMPACT

Active not recruiting

3,026 enrolled

BreastGastrointestinalThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Neoplasms, Unknown Primary, Urogenital Neoplasms, Colorectal Neoplasms

NCT05707286 2026-01-07

ICI-PICK

Completed

98 enrolled

DermatologicGastrointestinalSarcoma

Gastrointestinal Neoplasms, Melanoma, Sarcoma, Urogenital Neoplasms

Clinical Trials

STOP-VTE

Rapid Autopsy and Procurement of Cancer Tissue

Circulating Tumor DNA (ctDNA) for Early Treatment Response Assessment of Solid Tumors

SOGUG-PRINCIS

PROMES-URO

A Multi-Center Natural History of Urothelial Cancer and Rare Genitourinary Tract Malignancies

Discharge Medication Use Post-Operatively in GU Cancer Patients

IMPACT

ICI-PICK